Effect of repeated amiflamine administration on serotonergic and noradrenergic neurotransmission: electrophysiological studies in the rat CNS
- PMID: 3808082
- DOI: 10.1007/BF00508779
Effect of repeated amiflamine administration on serotonergic and noradrenergic neurotransmission: electrophysiological studies in the rat CNS
Abstract
Amiflamine is a selective and reversible inhibitor of monoamine oxidase (MAO) type A which exerts a preferential effect on serotonin (5-HT) catabolism. The present studies were undertaken to compare the effects of repeated administration of amiflamine (2 mg/kg, twice daily) on several aspects of the functioning of the 5-HT and norepinephrine (NE) systems in the rat CNS. The activity of MAO-A and B was assessed in forebrain slices and the whole brain contents of the neurotransmitters and their metabolites were determined by HPLC after 2-, 7- and 21-day treatments. MAO-A was inhibited by about 50% 2 h after the last dose and its activity was back to normal in rats sacrificed 12 h after the last dose. The activity of MAO-B was unaffected two or 12 h after the last dose. Whole brain concentration of 5-HT was increased to a greater degree than that of NE following repeated administration of amiflamine. These increases in 5-HT and NE were accompanied by decreased levels of their respective metabolites 5-hydroxy-indoleacetic acid and 3-methoxy-4-hydroxyphenylethyleneglycol. The firing activity of dorsal raphe 5-HT neurons, but not that of NE neurons, was markedly decreased 2-6 h after the last dose of a 2-day treatment. However, 2-6 h after a 21-day treatment, the firing activity of 5-HT neurons was back to normal, whereas that of NE neurons was decreased by 30%.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Modification of serotonergic and noradrenergic neurotransmissions by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat central nervous system.J Pharmacol Exp Ther. 1986 Jun;237(3):987-94. J Pharmacol Exp Ther. 1986. PMID: 2423685
-
Effects of acute and repeated administration of amiflamine on monoamine oxidase inhibition in the rat.Biochem Pharmacol. 1984 Sep 15;33(18):2839-47. doi: 10.1016/0006-2952(84)90205-3. Biochem Pharmacol. 1984. PMID: 6477643
-
Selective inhibition by amiflamine of monoamine oxidase type A in rat brain, liver and duodenum.Naunyn Schmiedebergs Arch Pharmacol. 1984 Aug;327(1):56-63. doi: 10.1007/BF00504992. Naunyn Schmiedebergs Arch Pharmacol. 1984. PMID: 6493351
-
Release of 3H-5-hydroxytryptamine by amiflamine and related phenylalkylamines from rat occipital cortex slices.Naunyn Schmiedebergs Arch Pharmacol. 1989 Jun;339(6):684-9. doi: 10.1007/BF00168662. Naunyn Schmiedebergs Arch Pharmacol. 1989. PMID: 2770890
-
Antidepressant monoamine oxidase inhibitors enhance serotonin but not norepinephrine neurotransmission.Psychopharmacol Ser. 1987;3:127-34. doi: 10.1007/978-3-642-71288-3_15. Psychopharmacol Ser. 1987. PMID: 3029752 Review. No abstract available.
Cited by
-
Effects of chronic treatment with zimelidine and REM sleep deprivation on the regulation of raphe neuronal activity in a rat model of depression.Psychopharmacology (Berl). 1996 Apr;124(3):267-74. doi: 10.1007/BF02246667. Psychopharmacology (Berl). 1996. PMID: 8740049
-
Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system.Cell Mol Neurobiol. 1989 Mar;9(1):1-44. doi: 10.1007/BF00711441. Cell Mol Neurobiol. 1989. PMID: 2565769 Free PMC article. Review.
-
The pharmacology of the neurochemical transmission in the midbrain raphe nuclei of the rat.Curr Neuropharmacol. 2006 Oct;4(4):313-39. doi: 10.2174/157015906778520764. Curr Neuropharmacol. 2006. PMID: 18654635 Free PMC article.